BNP Paribas Asset Management
IART icon

BNP Paribas Asset Management’s Integra LifeSciences IART Stock Holding History

BNP Paribas Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15K Buy
1,596
+415
+35% +$4.56K ﹤0.01% 2104
2025
Q4 		$15K Buy
+1,181
New +$15.7K ﹤0.01% 2036
2025
Q3 		– Sell
-859
Closed -$11K – 1964
2025
Q2 		$11K Buy
+859
New +$12.5K ﹤0.01% 1735

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BNP Paribas Asset Management's IART Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Integra LifeSciences (IART) stake by 35% in Q1 2026, buying an estimated $4.56K and bringing the position to 1,596 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #2104.

BNP Paribas Asset Management first reported a position in IART in Q2 2025 and has held it in 3 quarters since. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • BNP Paribas Asset Management held 1,596 shares of Integra LifeSciences worth $15K as of Q1 2026.
  • BNP Paribas Asset Management bought 415 Integra LifeSciences shares in Q1 2026, an estimated $4.56K.
  • Integra LifeSciences made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #2104 holding.
  • BNP Paribas Asset Management first reported a position in Integra LifeSciences in Q2 2025 and has held it in 3 quarters since.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.